Starting at Rs 3,500 per injection, with a monthly cost of up to Rs 14,000, Mounjaro enters India’s growing diabetes and ...

Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India after receiving regulatory approval. With rising ...

Sir Keir Starmer must urgently address problems with the NHS or risk missing out on future investment in Britain, the UK boss ...

And in January 2017 Lilly decided to walk away from the BioChaperone Lispro project for a second time. Adocia and Lilly's legal tussle intensifies as diabetes deal goes wrong | pharmaphorum Skip ...